PUBLISHER: TechSci Research | PRODUCT CODE: 1878862
PUBLISHER: TechSci Research | PRODUCT CODE: 1878862
Nanobodies Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Type By Application By End User, By Region, By Competition, 2020-2030F
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Nanobodies Market, valued at USD 578.4 Million in 2024, is projected to experience a CAGR of 18.30% to reach USD 1585.39 Million by 2030. Nanobodies, also known as single-domain antibodies, are compact antibody fragments derived from camelids, characterized by their small size, inherent stability, and high antigen affinity. These properties make them valuable for therapeutic, diagnostic, and research applications.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 578.4 Million |
| Market Size 2030 | USD 1585.39 Million |
| CAGR 2025-2030 | 18.3% |
| Fastest Growing Segment | Oncology |
| Largest Market | North America |
Key Market Drivers
The unique physicochemical properties of nanobodies constitute a primary driver for market expansion, owing to their compact size, inherent stability, and exceptional antigen-binding affinity. These attributes facilitate superior tissue penetration and the targeting of cryptic epitopes, often inaccessible to larger conventional antibodies, thus broadening their therapeutic utility. Nanobodies also exhibit lower immunogenicity, reducing the risk of adverse immune responses. The substantial potential of these characteristics attracts significant investment into companies leveraging nanobody platforms.
Key Market Challenges
The high cost associated with nanobody development and large-scale production represents a major barrier to the expansion of the global nanobodies market. These elevated expenses stem from the complex biotechnological processes, specialised expertise, and advanced infrastructure required throughout the discovery, development, and manufacturing stages. As a result, financial constraints limit the number of nanobody-based therapeutics and diagnostic products that successfully transition from research to commercialisation, thereby slowing overall market growth.
Key Market Trends
Advancements in nanobody production and bioprocessing technologies are significantly influencing the global market by enhancing scalability and reducing manufacturing complexities. The Parenteral Drug Association (PDA), at its 2024 Pharmaceutical Manufacturing & Quality Conference, extensively discussed the adoption of multiple advanced techniques, including flexible manufacturing, continuous manufacturing, and process analytical technology, to optimize bioprocessing efficiency. This focus underscores the industry's drive to streamline production and improve quality control.
Key Market Players
- Hybrigenics Services
- Novo Nordisk A/S
- Merck KGaA
- Bristol Myers Squibb Company
- Boehringer Ingelheim International GmbH
- Sanofi S.A
- Beroni Group
- Shenzhen Kangti Co., Ltd.
- GlaxoSmithKline plc
- Sensei Biotherapeutics, Inc
Report Scope:
In this report, the Global Nanobodies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Nanobodies Market, By Type:
- Mono-Specific
- Multi-Specific
Nanobodies Market, By Application:
- Acquired Thrombotic Thrombocytopenic Purpura (TTP)
- Respiratory Syncytial Virus Infection
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Oncology
- Psoriasis
- Chronic Kidney Diseases
- Bone Disorders
- Others
Nanobodies Market, By End User:
- Pharmaceutical & Biotechnology Companies
- Research Laboratories
- Others
Nanobodies Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Nanobodies Market.
Available Customizations:
Global Nanobodies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Nanobodies Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Mono-Specific, Multi-Specific)
- 5.2.2. By Application (Acquired Thrombotic Thrombocytopenic Purpura (TTP), Respiratory Syncytial Virus Infection, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Oncology, Psoriasis, Chronic Kidney Diseases, Bone Disorders, Others)
- 5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
- 5.3. Market Map
6. North America Nanobodies Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By End User
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Nanobodies Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By Application
- 6.3.1.2.3. By End User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Nanobodies Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By Application
- 6.3.2.2.3. By End User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Nanobodies Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By Application
- 6.3.3.2.3. By End User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Nanobodies Market Outlook
7. Europe Nanobodies Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Nanobodies Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. France Nanobodies Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Nanobodies Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Nanobodies Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By Application
- 7.3.4.2.3. By End User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Nanobodies Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By Application
- 7.3.5.2.3. By End User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Nanobodies Market Outlook
8. Asia Pacific Nanobodies Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Nanobodies Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Nanobodies Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Nanobodies Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Nanobodies Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Nanobodies Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Nanobodies Market Outlook
9. Middle East & Africa Nanobodies Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
- 9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Nanobodies Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. UAE Nanobodies Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. South Africa Nanobodies Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Saudi Arabia Nanobodies Market Outlook
10. South America Nanobodies Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By End User
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Nanobodies Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Colombia Nanobodies Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Argentina Nanobodies Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Nanobodies Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Nanobodies Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Hybrigenics Services
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
- 15.2. Novo Nordisk A/S
- 15.3. Merck KGaA
- 15.4. Bristol Myers Squibb Company
- 15.5. Boehringer Ingelheim International GmbH
- 15.6. Sanofi S.A
- 15.7. Beroni Group
- 15.8. Shenzhen Kangti Co., Ltd.
- 15.9. GlaxoSmithKline plc
- 15.10. Sensei Biotherapeutics, Inc
16. Strategic Recommendations
17. About Us & Disclaimer
